BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19935642)

  • 1. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
    Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
    Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
    Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
    J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
    Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
    Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: International guidelines for assay characteristics.
    Horna P; Wang SA; Wolniak KL; Psarra K; Almeida J; Illingworth AJ; Johansson U; Craig FE; Torres R
    Cytometry B Clin Cytom; 2021 Mar; 100(2):142-155. PubMed ID: 32319723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
    Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
    Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.
    Pulitzer MP; Horna P; Almeida J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sézary syndrome and mycosis fungoides flow cytometric evaluation: The clinicians' perspective.
    Guitart J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):129-131. PubMed ID: 32017375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CD24-related epitopes in mycosis fungoides/Sézary syndrome: a potential marker for circulating Sézary cells.
    Pirruccello SJ; Lang MS
    Blood; 1990 Dec; 76(11):2343-7. PubMed ID: 1701668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIGIT and Helios Are Highly Expressed on CD4
    Jariwala N; Benoit B; Kossenkov AV; Oetjen LK; Whelan TM; Cornejo CM; Takeshita J; Kim BS; Showe LC; Wysocka M; Rook AH
    J Invest Dermatol; 2017 Jan; 137(1):257-260. PubMed ID: 27592800
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
    Morice WG; Katzmann JA; Pittelkow MR; el-Azhary RA; Gibson LE; Hanson CA
    Am J Clin Pathol; 2006 Mar; 125(3):364-74. PubMed ID: 16613339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
    Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
    Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P; Moscinski LC; Sokol L; Shao H
    Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
    Kelemen K; Guitart J; Kuzel TM; Goolsby CL; Peterson LC
    Am J Clin Pathol; 2008 Jan; 129(1):146-56. PubMed ID: 18089499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
    Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
    J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunophenotyping on simultaneously occurring plaques and tumours in mycosis fungoides and Sézary syndrome.
    Preesman AH; Toonstra J; van der Putte SC; van Vloten WA
    Br J Dermatol; 1993 Dec; 129(6):660-6. PubMed ID: 8286248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.